|
1
|
Li H, Xie S, Liu M, Chen Z, Liu X, Wang L,
Li D and Zhou Y: The clinical significance of downregulation of
mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric
cancer tumorigenesis. Int J Oncol. 45:197–208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maiarù M, Morgan OB, Tochiki KK, Hobbiger
EJ, Rajani K, Overington DW and Géranton SM: Complex regulation of
the regulator of synaptic plasticity histone deacetylase 2 in the
rodent dorsal horn after peripheral injury. J Neurochem.
138:222–232. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang SE, Ko SY, Jo S, Choi M, Lee SH, Jo
HR, Seo JY, Lee SH, Kim YS, Jung SJ, et al: TRPV1 regulates stress
responses through HDAC2. Cell Rep. 19:401–412. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang X, Li Y, Dai Y, Liu Q, Ning S, Liu J,
Shen Z, Zhu D, Jiang F, Zhang J, et al: Sulforaphane improves
chemotherapy efficacy by targeting cancer stem cell-like properties
via the miR-124/IL-6R/STAT3 axis. Sci Rep. 6:367962016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Y, Li H, Han J and Zhang Y:
Down-regulation of microRNA-124 is correlated with tumor metastasis
and poor prognosis in patients with lung cancer. Int J Clin Exp
Pathol. 8:1967–1972. 2015.PubMed/NCBI
|
|
6
|
Wang M, Gu H, Wang S, Qian H, Zhu W, Zhang
L, Zhao C, Tao Y and Xu W: Circulating miR-17-5p and miR-20a:
Molecular markers for gastric cancer. Mol Med Rep. 5:1514–1520.
2012.PubMed/NCBI
|
|
7
|
Pei L, Xia JZ, Huang HY, Zhang RR, Yao LB,
Zheng L and Hong B: Role of miR-124a methylation in patients with
gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 14:136–139.
2011.(In Chinese). PubMed/NCBI
|
|
8
|
Xie L, Zhang Z, Tan Z, He R, Zeng X, Xie
Y, Li S, Tang G, Tang H and He X: MicroRNA-124 inhibits
proliferation and induces apoptosis by directly repressing EZH2 in
gastric cancer. Mol Cell Biochem. 392:153–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiao HJ, Ji Q, Yang L, Li RT, Zhang C and
Hou JM: In vivo and in vitro effects of microRNA-124 on human
gastric cancer by targeting JAG1 through the Notch signaling
pathway. J Cell Biochem. 119:2520–2534. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang TH, Liang LZ, Liu XL, Wu JN, Su K,
Chen JY, Zheng QY, Huang HZ and Liao GQ: Long non-coding RNA MALAT1
interacts with miR-124 and modulates tongue cancer growth by
targeting JAG1. Oncol Rep. 37:2087–2094. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu L, Ye JX, Qin YZ, Chen QH and Ge LY:
Evaluation of miR-29c, miR-124, miR-135a and miR-148a in predicting
lymph node metastasis and tumor stage of gastric cancer. Int J Clin
Exp Med. 8:22227–22236. 2015.PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Costa WL Jr, Coimbra FJ, Fogaroli RC,
Ribeiro HS, Diniz AL, Begnami MD, Mello CA, Fanelli MF, Silva MJ,
Fregnani JH, et al: Adjuvant chemoradiotherapy after
d2-lymphadenectomy for gastric cancer: The role of n-ratio in
patient selection. results of a single cancer center. Radiat Oncol.
7:1692012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou J, Zhou J, Wang W, Li W, Wu L, Li G,
Shi J and Zhou S: The polymorphism in miR-25 attenuated the
oncogenic function in gastric cancer. Tumour Biol. 37:5515–5520.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maeda M, Yamashita S, Shimazu T, Iida N,
Takeshima H, Nakajima T, Oda I, Nanjo S, Kusano C, Mori A, et al:
Novel epigenetic markers for gastric cancer risk stratification in
individuals after Helicobacter pylori eradication. Gastric Cancer
1113. 1–11. 2018.
|
|
17
|
Yuan Q, Sun T, Ye F, Kong W and Jin H:
MicroRNA-124-3p affects proliferation, migration and apoptosis of
bladder cancer cells through targeting AURKA. Cancer Biomark.
19:93–101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang T, Zhou Y, Zhang J, Wong CC, Li W,
Kwan JSH, Yang R, Chan AKY, Dong Y, Wu F, et al: SRGAP1, a crucial
target of miR-340 and miR-124, functions as a potential oncogene in
gastric tumorigenesis. Oncogene. 37:1159–1174. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu CB, Li QL, Hu JF, Zhang Q, Xie JP and
Deng L: miR-124 inhibits growth and invasion of gastric cancer by
targeting ROCK1. Asian Pac J Cancer Prev. 15:6543–6546. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pan Y, Wu A, Xu F, Chen C, Jiang L and Jin
R: Lentivirus-mediated overexpression of miR-124 suppresses growth
and invasion by targeting JAG1 and EZH2 in gastric cancer. Oncol
Lett. 15:7450–7458. 2018.PubMed/NCBI
|
|
21
|
Li SL, Gao HL, Lv XK, Hei YR, Li PZ, Zhang
JX and Lu N: MicroRNA-124 inhibits cell invasion and
epithelial-mesenchymal transition by directly repressing Snail2 in
gastric cancer. Eur Rev Med Pharmacol Sci. 21:3389–3396.
2017.PubMed/NCBI
|
|
22
|
Xia J, Wu Z, Yu C, He W, Zheng H, He Y,
Jian W, Chen L, Zhang L and Li W: miR-124 inhibits cell
proliferation in gastric cancer through down-regulation of SPHK1. J
Pathol. 227:470–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang L, Lin T, Xu C, Hu S, Pan Y and Jin
R: miR-124 interacts with the Notch1 signalling pathway and has
therapeutic potential against gastric cancer. J Cell Mol Med.
20:313–322. 2016. View Article : Google Scholar : PubMed/NCBI
|
